Endocyte Company Profile (NASDAQ:ECYT)

About Endocyte

Endocyte Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. The Company uses its technology to create small molecule drug conjugates (SMDCs) and companion imaging diagnostics. The Company's pipeline includes Folate-Tubulysin (EC1456), the Company's second generation SMDC, also targets the folate receptor; PSMA Tubulysin (EC1169), the Company's non-folate SMDC, which is a tubulysin therapeutic targeting PSMA; Vintafolide (Folate DAVLBH), SMDC, vintafolide, targets the folate receptor with the anti-cancer drug payload DAVLBH; Folate-DNA alkylator (EC1788), which is a folate receptor-targeted SMDC with a potent DNA alkylator drug; Folate-Aminopterin (EC1669) is a folate receptor-targeted SMDC for the treatment in inflammatory diseases, and Folate-mTor inhibitor (EC0371), which is a folate receptor-targeted SMDC for the treatment of polycystic kidney disease(PKD).

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceuticals
• Exchange: NASDAQ
• Symbol: ECYT
• CUSIP: 29269A10

Key Metrics:

• Previous Close: $3.13
• 50 Day Moving Average: $3.07
• 200 Day Moving Average: $3.39
• 52-Week Range: $2.65 - $5.63
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -2.46
• P/E Growth: 0.00
• Market Cap: $132.28M
• Outstanding Shares: 42,263,000
• Beta: 1.27

Profitability:

• Net Margins: -58,957.14%
• Return on Equity: -24.71%
• Return on Assets: -23.86%

Debt:

• Current Ratio: 34.32%
• Quick Ratio: 34.32%

Additional Links:

• Visit Endocyte's Official Website
• View ECYT on Google Finance
• View ECYT on Yahoo Finance
• View ECYT's Company Profile on Reuters
• Search for Endocyte Inc. on Google

Companies Related to Endocyte:

• Zogenix (NASDAQ:ZGNX)
• Nutraceutical International Corp. (NASDAQ:NUTR)
• Antares Pharma (NASDAQ:ATRS)
• Aquinox Pharmaceuticals (NASDAQ:AQXP)
• Concordia Healthcare Corp. (NASDAQ:CXRX)
• ImmunoGen (NASDAQ:IMGN)
• Fluidigm Corp. (NASDAQ:FLDM)
• Tandem Diabetes Care (NASDAQ:TNDM)
• ChemoCentryx (NASDAQ:CCXI)
• Syneron Medical (NASDAQ:ELOS)

Earnings

Earnings History for Endocyte (NASDAQ:ECYT)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/1/2016
8/4/2016	Q2	($0.26)	($0.25)			View	N/A
5/4/2016	Q116	($0.25)	($0.24)			View	Listen
3/2/2016	Q4	($0.27)	($0.23)		$0.01 million	View	Listen
11/3/2015	Q315	($0.27)	($0.24)		$0.03 million	View	N/A
8/4/2015	Q215	($0.30)	($0.25)			View	N/A
5/7/2015	Q115	($0.24)	($0.26)			View	N/A
3/2/2015	Q414	($0.25)	($0.19)	$2.55 million	$12.00 million	View	N/A
11/5/2014	Q314	($0.21)	($0.14)	$5.10 million	$3.90 million	View	N/A
7/29/2014	Q214	$0.10	$0.52	$26.62 million	$49.17 million	View	N/A
5/2/2014	Q114	($0.14)	($0.09)	$15.07 million	$17.30 million	View	N/A
2/24/2014	Q413	($0.14)	($0.08)	$15.90 million	$17.30 million	View	N/A
5/2/2013	Q1 2013	($0.06)	($0.11)	$14.24 million	$14.50 million	View	N/A
4/15/2013	Q413		($0.10)	$8.50 million	$13.60 million	View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endocyte (NASDAQ:ECYT)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.29)	($0.27)	($0.28)
Q2 2016	2	($0.29)	($0.27)	($0.28)
Q3 2016	2	($0.30)	($0.29)	($0.30)
Q4 2016	1	($0.29)	($0.29)	($0.29)
Q1 2017	1	($0.32)	($0.32)	($0.32)
Q2 2017	1	($0.33)	($0.33)	($0.33)
Q3 2017	1	($0.33)	($0.33)	($0.33)
Q4 2017	1	($0.34)	($0.34)	($0.34)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endocyte (NASDAQ:ECYT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endocyte (NASDAQ:ECYT)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
5/10/2016	Philip S Low	Insider	Buy	11,375	$3.52	$40,040.00
1/19/2016	Fred A. Middleton	Director	Buy	10,000	$2.79	$27,900.00
1/15/2016	Fred A. Middleton	Director	Buy	20,000	$2.80	$56,000.00
4/9/2014	Allen Ritter	VP	Sell	1,000	$21.16	$21,160.00
3/21/2014	Allen Ritter	VP	Sell	8,000	$33.11	$264,880.00
2/14/2014	Philip Low	Insider	Sell	6,000	$15.00	$90,000.00
12/2/2013	P Ron Ellis	CEO	Sell	3,000	$12.00	$36,000.00
9/16/2013	Allen Ritter	VP	Sell	2,000	$17.06	$34,120.00
9/12/2013	David Meek	Insider	Sell	10,000	$15.50	$155,000.00
9/3/2013	P Ron Ellis	CEO	Sell	3,000	$14.54	$43,620.00
8/30/2013	Allen Ritter	VP	Sell	6,000	$14.36	$86,160.00
8/6/2013	Chandra Lovejoy	VP	Sell	7,000	$17.29	$121,030.00
8/1/2013	P Ron Ellis	CEO	Sell	3,000	$18.12	$54,360.00
7/15/2013	P Ron Ellis	CEO	Sell	3,000	$17.01	$51,030.00
5/28/2013	Ann Hanham	Director	Sell	9,900	$14.10	$139,590.00
5/22/2013	Ann Hanham	Director	Sell	40,000	$14.38	$575,200.00
5/17/2013	Ann Hanham	Director	Sell	37,200	$14.41	$536,052.00
5/17/2013	Binh Nguyen	VP	Sell	17,300	$14.42	$249,466.00
5/15/2013	Ann Hanham	Director	Sell	40,200	$14.69	$590,538.00
5/14/2013	Christopher P Leamon	VP	Sell	5,000	$14.70	$73,500.00
2/25/2013	Chandra D Lovejoy	VP	Sell	2,102	$9.70	$20,389.40
12/26/2012	Chandra D Lovejoy	VP	Sell	2,209	$9.05	$19,991.45
11/26/2012	Chandra D Lovejoy	VP	Sell	2,209	$8.72	$19,262.48

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Endocyte (NASDAQ:ECYT)

Date	Headline
	What are Research Firms Saying About Endocyte, Inc. (NASDAQ:ECYT)? - Frisco Fastball (NASDAQ:ECYT) friscofastball.com - September 24 at 9:25 AM
	Shares Of Endocyte, Inc. (NASDAQ:ECYT) Expected To Hit $8 - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - September 22 at 10:21 AM
	Endocyte, Inc. (ECYT) Given Outperform Rating at Wedbush - DailyQuint (NASDAQ:ECYT) dailyquint.com - September 21 at 9:03 AM
	Penny Stock Investors Take an Interest in Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 21 at 9:03 AM
	Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:ECYT) finance.yahoo.com - September 21 at 9:02 AM
	Under the Microscope: Getting a Closer Look at Shares of Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 19 at 3:37 PM
	Check on Share Volatility: Endocyte, Inc. (NASDAQ:ECYT) - DailyQuint (NASDAQ:ECYT) dailyquint.com - September 17 at 4:38 PM
	Stock Update, a Closer Look at Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 15 at 5:06 PM
	Keen Investors Narrowing Their Focus on Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 14 at 9:57 PM
	Stock Perspective: Endocyte, Inc. (NASDAQ:ECYT) Earnings in View - Frisco Fastball (NASDAQ:ECYT) friscofastball.com - September 13 at 9:38 AM
	Getting a Closer Look at Shares of Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 12 at 4:35 PM
	Getting a Closer Look at Shares of Endocyte, Inc. (NASDAQ:ECYT) - Duncan Research (NASDAQ:ECYT) www.duncanindependent.com - September 12 at 4:35 PM
	Placing Endocyte, Inc. (NASDAQ:ECYT) Shares Under the Microscope - Post News (NASDAQ:ECYT) www.kentuckypostnews.com - September 9 at 4:38 PM
	Stock Struggling for the Quarter: Endocyte, Inc. (NASDAQ:ECYT) - Post News (NASDAQ:ECYT) www.kentuckypostnews.com - September 4 at 4:27 PM
	ETF’s with exposure to Endocyte, Inc. : September 2, 2016 (NASDAQ:ECYT) www.capitalcube.com - September 2 at 4:41 PM
	Stock in Review: Taking a Closer Look at Endocyte, Inc. (NASDAQ:ECYT) Shares - Post News (NASDAQ:ECYT) www.kentuckypostnews.com - September 2 at 9:39 AM
	Endocyte, Inc. (NASDAQ:ECYT) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - August 24 at 4:42 PM
	Will Endocyte, Inc. (NASDAQ:ECYT) Hit $8 Price Target? - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - August 17 at 4:57 PM
	ENDOCYTE INC Financials (NASDAQ:ECYT) finance.yahoo.com - August 16 at 4:49 PM
	Endocyte Announces Presentations at the 252nd American Chemical Society National Meeting & Exposition (NASDAQ:ECYT) finance.yahoo.com - August 15 at 4:53 PM
	ETF’s with exposure to Endocyte, Inc. : August 15, 2016 (NASDAQ:ECYT) www.capitalcube.com - August 15 at 11:58 AM
	Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ECYT) www.capitalcube.com - August 12 at 4:46 PM
	Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference - GlobeNewswire (press release) (NASDAQ:ECYT) globenewswire.com - August 10 at 4:57 PM
	Endocyte (ECYT) Q2 Loss Wider than Expected (Revised) - Nasdaq (NASDAQ:ECYT) www.nasdaq.com - August 9 at 8:59 PM
	Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:ECYT) finance.yahoo.com - August 9 at 8:59 PM
	Endocyte (ECYT) Q2 Loss Wider than Expected (Revised) (NASDAQ:ECYT) finance.yahoo.com - August 9 at 7:46 AM
	Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q2 (NASDAQ:ECYT) finance.yahoo.com - August 5 at 4:48 PM
	Edited Transcript of ECYT earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:ECYT) finance.yahoo.com - August 5 at 4:48 PM
	ENDOCYTE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:ECYT) biz.yahoo.com - August 5 at 4:48 PM
	Earnings Reaction History: Endocyte, Inc., 80.0% Follow-Through Indicator, 14.6% Sensitive - Nasdaq (NASDAQ:ECYT) www.nasdaq.com - August 5 at 8:17 AM
	Endocyte Inc.: Endocyte Reports Second Quarter 2016 Financial Results (NASDAQ:ECYT) www.twst.com - August 4 at 10:29 PM
	Endocyte reports 2Q loss (NASDAQ:ECYT) sg.finance.yahoo.com - August 4 at 10:29 PM
	Endocyte Reports Second Quarter 2016 Financial Results (NASDAQ:ECYT) www.publicnow.com - August 4 at 4:58 PM
	Endocyte Inc. (ECYT) is Trading Lower on Unusual Volume for August 02 - Equities.com (NASDAQ:ECYT) www.equities.com - August 4 at 7:53 AM
	Endocyte Announces Second Quarter 2016 Earnings Conference Call (NASDAQ:ECYT) www.publicnow.com - July 28 at 4:18 PM
	Whta's in Store for Endocyte (ECYT) this Earnings Season? (NASDAQ:ECYT) finance.yahoo.com - July 28 at 10:59 AM
	Can Shares Of Endocyte, Inc. (NASDAQ:ECYT) Hit $8? - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - July 27 at 4:53 PM
	Earnings Focus and Crowd Sourced Sentiment Review for Endocyte, Inc. (NASDAQ:ECYT) - TGP (NASDAQ:ECYT) telanaganapress.com - July 22 at 8:16 AM
	ETF’s with exposure to Endocyte, Inc. : July 21, 2016 (NASDAQ:ECYT) www.capitalcube.com - July 21 at 1:57 PM
	Is $8 Price Target Attainable For Endocyte, Inc. (NASDAQ:ECYT)? - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - July 21 at 8:15 AM
	Endocyte Incorporated (NASDAQ:ECYT) Sellers Covered 7.44% of Their Shorts - Consumer Eagle (NASDAQ:ECYT) www.consumereagle.com - July 20 at 5:58 PM
	Were Analysts Bearish Endocyte, Inc. (NASDAQ:ECYT) This Week? - Consumer Eagle (NASDAQ:ECYT) www.consumereagle.com - July 20 at 7:55 AM
	Equity Roundup: Stock Performance Focus on Endocyte, Inc. (NASDAQ:ECYT) - Press Telegraph (NASDAQ:ECYT) presstelegraph.com - July 19 at 10:52 AM
	Shares Moving Down on the Week: Endocyte, Inc. (NASDAQ:ECYT) - Engelwood Daily (NASDAQ:ECYT) www.engelwooddaily.com - July 18 at 4:53 PM
	Endocyte Incorporated (NASDAQ:ECYT) Shorted Shares Decreased By 8.99% - Press Telegraph (NASDAQ:ECYT) presstelegraph.com - July 15 at 11:47 AM
	Insiders Increasing Positions in: Endocyte, Inc. (NASDAQ:ECYT) - Press Telegraph (NASDAQ:ECYT) presstelegraph.com - July 15 at 11:47 AM
	Crowd Rating and Earnings Recap for Endocyte, Inc. (NASDAQ:ECYT) - Telanagana Press (NASDAQ:ECYT) telanaganapress.com - July 15 at 11:47 AM
	Endocyte, Inc. (NASDAQ:ECYT) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ECYT) telanaganapress.com - July 14 at 5:40 AM
	Strong Sell Calls For Endocyte, Inc. (NASDAQ:ECYT) At 0 - Investor Newswire (NASDAQ:ECYT) www.investornewswire.com - July 14 at 5:40 AM
	Earnings Check and Company Target Review for Endocyte, Inc. (NASDAQ:ECYT) - Press Telegraph (NASDAQ:ECYT) presstelegraph.com - July 13 at 4:57 PM

Social

Endocyte (NASDAQ:ECYT) Chart for Saturday, September, 24, 2016